DIALYSIS · CCN 292548

DaVita Cheyenne Dialysis

LAS VEGAS, NV 89129

DialysisProfitDaVita
$9.4M
TOTAL REVENUE
42.1%
OPERATING MARGIN
1 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$9.4M
Total costs
$5.4M
Operating income (rev − costs)
$4.0M
Operating margin
42.1%
Total charges
$9.2M
Total treatments
18,264
Dialysis stations
26

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.7879—
Fistula Rate
DFC_FISTULA_RATE
55.4115—
Five Star Rating
DFC_FIVE_STAR
1——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.3761—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
157.4139—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
17115—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
25.2595—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
8.6137—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
43.7102—
Standardized ED Visits Ratio
DFC_SEDR
0.566—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
3360—